Barry Cherney

Latest from Barry Cherney

Next-Generation Biotechnology Product Development, Manufacturing, and Control Strategies, Part 2: Process Modeling and Analytics
CMC Forums
Next-Generation Biotechnology Product Development, Manufacturing, and Control Strategies, Part 2: Process Modeling and AnalyticsNext-Generation Biotechnology Product Development, Manufacturing, and Control Strategies, Part 2: Process Modeling and Analytics
byAnthony Mire-Sluis, Sarah Kennettand 8 more
Dec 17, 2020
Next-Generation Biotechnology Product Development, Manufacturing, and Control Strategies, Part 1: Upstream and Downstream Strategies
CMC Forums
Next-Generation Biotechnology Product Development, Manufacturing, and Control Strategies, Part 1: Upstream and Downstream StrategiesNext-Generation Biotechnology Product Development, Manufacturing, and Control Strategies, Part 1: Upstream and Downstream Strategies
byAnthony Mire-Sluis, Sarah Kennettand 7 more
Oct 29, 2020

All from Barry Cherney

Myths, Risks, and Best Practices: Production Cell Line Development and Control of Product Consistency During Cell Cultivation
Cell Line Development
Myths, Risks, and Best Practices: Production Cell Line Development and Control of Product Consistency During Cell Cultivation
Myths, Risks, and Best Practices: Production Cell Line Development and Control of Product Consistency During Cell Cultivation
Sep 19, 2018
+3
byBarry Cherney, Dieter Schmalzingand 3 more
eBook: Production Cell-Line Development and Control of Product Consistency During Cultivation — Myths, Risks, and Best Practices
Cell Line Development
eBook: Production Cell-Line Development and Control of Product Consistency During Cultivation — Myths, Risks, and Best Practices
eBook: Production Cell-Line Development and Control of Product Consistency During Cultivation — Myths, Risks, and Best Practices
Apr 30, 2018
+3
byBarry Cherney, Dieter Schmalzingand 3 more
CMC Strategy Forum Special Focus Series: Part 2 Product-Related Impurities, An Overview
CMC Forums
CMC Strategy Forum Special Focus Series: Part 2 Product-Related Impurities, An Overview
CMC Strategy Forum Special Focus Series: Part 2 Product-Related Impurities, An Overview
Apr 12, 2016
+18
byCheryl Scott, Siddharth J. Advant, PhDand 18 more
Reference Standards for Therapeutic Proteins: Current Regulatory and Scientific Best Practices logo in a gray background | Reference Standards for Therapeutic Proteins: Current Regulatory and Scientific Best Practices
Assays
Reference Standards for Therapeutic Proteins: Current Regulatory and Scientific Best Practices
Reference Standards for Therapeutic Proteins: Current Regulatory and Scientific Best Practices
Mar 1, 2014
+3
byAnthony Mire- Sluis, Nadine Ritterand 3 more
Analysis and Immunogenic Potential of Aggregates and Particles logo in a gray background | Analysis and Immunogenic Potential of Aggregates and Particles
QA/QC
Analysis and Immunogenic Potential of Aggregates and Particles
Analysis and Immunogenic Potential of Aggregates and Particles
Dec 1, 2011
+6
byAnthony Mire- Sluis, Barry Cherneyand 6 more
Analysis and Immunogenic Potential of Aggregates and Particles logo in a gray background | Analysis and Immunogenic Potential of Aggregates and Particles
QA/QC
Analysis and Immunogenic Potential of Aggregates and Particles November 2011
Analysis and Immunogenic Potential of Aggregates and Particles November 2011
Nov 1, 2011
+6
byAnthony Mire- Sluis, Barry Cherneyand 6 more

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Ask the Expert webcasts
ATE Webcasts
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Ask the Expert webcasts
ATE Webcasts
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Insider News
See all
Dec 2 - Dec 5, 2024
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success
Learn More

Innovative Technology

Emerson white paper
Sponsored Content
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency

Nov 12, 2024

WuXi Bio white paper
Sponsored Content
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products

Nov 8, 2024

Bora white paper
Sponsored Content
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages

Nov 8, 2024